increased sensitivity to induced morbidity/mortality_Kit<W>/Kit<W-v>

http://metadb.riken.jp/0009763WBReJxC57BL6JKitWvJF1KitWKitWvJKitWKitWvKitWKitWv

increased sensitivity to induced morbidity/mortality_Kit<W>/Kit<W-v>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• KIT proto-oncogene receptor tyrosine kinase
  http://metadb.riken.jp/db/mgi_rdf/MGI:96677

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Kit<W>/Kit<W-v>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Kit<W>|Kit<W-v>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• (WB/ReJ x C57BL/6J-Kit<W-v>/J)F1-Kit<W>/Kit<W-v>/J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased sensitivity to induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009763

文献

http://purl.org/net/cito/citesAsAuthority

• Kathrin. Hochegger, et.al., Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis., European journal of immunology, 2005, 35
  http://rdf.ncbi.nlm.nih.gov/pubmed/16180252